docslib-293646v18k_forrei
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 8-K
_________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
April 1, 2022
_________________________________________________
SCIENTIFIC INDUSTRIES, INC.
_________________________________________________
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-6658
|
|
04-2217279
|
(State
or other Jurisdiction)
|
|
(Commission
File Number)
|
|
(IRS
Employer No.)
|
80 Orville Drive
Bohemia, New York 11716
__________________________________________________
(Address
of principal executive offices)
(631) 567-4700
__________________________________________________
(Registrant's
telephone number, including area code)
Not Applicable
__________________________________________________
(Former
name or former address, if changed since last report)
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS
Effective
April 1, 2022, by mutual agreement between the Company, Mr.
Reinhard Vogt and his affiliate Societät Reinhard and Noah
Vogt AG o GmbH, the consulting agreement among them dated July 20,
2020, as amended, was terminated and, the ninety (90) day notice
period required under the agreement was waived and the Company made
a single payment to Mr. Vogt of the consulting fees that would
otherwise have been payable by the Company during such notice
period. In connection with such termination, Mr. Vogt resigned from
his positions as a Class A Director of the Company’s Board of
Directors, Chairman of the Company’s indirect wholly-owned
subsidiary, Scientific Bioprocessing Inc. (”SBI”), and
director of the Company’s wholly-owned subsidiary, Scientific
Bioprocessing Holdings, Inc. Mr. Vogt continues to be bound by
non-competition and confidentiality clauses under the terminated
agreement.
Effective
April 4, 2022, the Company’s Board of Directors appointed Mr.
John A. Moore as SBI’s Chairman, and Mr. Daniel Gruenes was
elected as SBI’s new Chief Executive Officer and President.
Mr. Gruenes currently serves as the Vice President of Operations
and Research and Development of SBI.
ITEM 9.01 Financial Statements and Exhibits
(a) and
(b) not applicable
(c)
Exhibits
None
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
SCIENTIFIC INDUSTRIES, INC.
|
|
|
|
|
|
|
|
|
Date: April 5, 2022
|
By:
|
/s/ Helena R. Santos
|
|
|
|
Helena R. Santos,
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|